Research collaboration, scoped with clarity.
From study question to structured outputs — VAMS LABS™ supports microbiome research with sequencing coordination, bioinformatics, pilot studies and method-bounded report frameworks, under consent-aware arrangements.
Who this is for
Research teams we work with
Collaboration models
Ways to collaborate — and their status
Before scoping
Project checklist
What we decide together
Scoping the study
FAQ
Collaboration questions
Can you work with university or hospital research teams?
Yes — we work with academic, clinical-research and biotech teams on research-use, consent-aware projects. Data governance and ethics context are confirmed during scoping.
Can you help with study design?
Yes — we can help decide sample type, method, metadata, cohort design, sequencing depth, deliverables and reporting framework during scoping.
Do you support publications or grants?
This is discussed during scoping and offered only where founder-approved. We do not claim publication or grant outcomes.
Are outputs diagnostic?
No. Outputs are research-use and method-bounded unless a separately approved, formally contracted pathway exists.
How is consent and data governance handled?
Consent and governance context are confirmed during scoping. De-identified aggregate reporting is only used where consent and governance allow.
Related pathways
Scope a microbiome research collaboration
Share your research question, sample type and study design. We’ll confirm method fit, deliverables and governance before any project begins.
Collaboration architecture
From study question to reproducible outputs.
A collaboration is scoped as an architecture: question, participants, sampling matrix and a pinned pipeline — with provenance carried through so results can be reconstructed.
01 · Research question
A question fixed before collection begins — cohort, comparison, timeframe and endpoint defined up front, so the design is answerable rather than exploratory after the fact.
02 · Participants
Strata defined, consent scoped
Eligibility, arm allocation and the consent scope for secondary use are recorded before the first sample is issued.
03 · Metadata schema
The same fields, every visit
A fixed schema captured at each timepoint. Fields added mid-study create gaps that cannot be filled retrospectively.
04 · Longitudinal sampling
Repeat sampling on a fixed cadence. A missed timepoint is recorded as missing, never back-filled.
05 · Sequencing
Batched with controls
Runs carry negative and positive controls; batch identity travels with every sample.
06 · Analysis
Pinned pipeline, pinned parameters
Analysis runs against a versioned pipeline and a recorded parameter set, so the same inputs give the same output.
07 · Reproducibility — the provenance record
- Participant ID (pseudonymised)
- Arm and timepoint
- Collection metadata
- Kit and batch lot
- Protocol version
- Extraction and run ID
- Pipeline version
- Parameter set
Shared VAMS infrastructure
- Kits & custody
- Sequencing partners
- ATLAS interpretation
- Structured reporting
-
ClinicRequesting practice
Brings the request and the clinical context; takes back a structured report.
-
LaboratoryPartner laboratory
Brings sequencing capacity under a fixed protocol; takes back scheduling and custody data.
-
EnterpriseProgramme sponsor
Brings distributed populations; takes back aggregate, de-identified programme reporting.
-
HospitalProposed integration
A proposed route for clinical data integration. Not built, not deployed, not endorsed by any institution.
Proposed — not built -
ResearchCohorts and studies
Brings study design and consented cohorts; takes back versioned, reproducible analysis.